Kezar Life Sciences Inc (KZR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 0 | 7,000 | 0 | 0 | 0 |
| Gross Profit | N/A | 7,000 | N/A | N/A | N/A |
| Operating Expenses | 90,605 | 118,424 | 71,162 | 54,659 | 42,950 |
| Operating Income | -90,605 | -111,424 | -71,162 | -54,659 | -42,950 |
| Interest Expense | 1,593 | 1,550 | 1,185 | 159 | 0 |
| Other Income | 8,462 | 11,104 | 4,108 | 188 | 1,208 |
| Pre-tax Income | -83,736 | -101,870 | -68,239 | -54,630 | -41,742 |
| Net Income Continuous | -83,736 | -101,870 | -68,239 | -54,630 | -41,742 |
| Net Income | $-83,736 | $-101,870 | $-68,239 | $-54,630 | $-41,742 |
| EPS Basic Total Ops | -11.49 | -14.04 | -10.13 | -10.40 | -9.50 |
| EPS Basic Continuous Ops | -11.49 | -14.04 | -10.13 | -10.35 | -9.49 |
| EPS Diluted Total Ops | -11.49 | -14.04 | -10.13 | -10.40 | -9.50 |
| EPS Diluted Continuous Ops | -11.49 | -14.04 | -10.13 | -10.35 | -9.49 |
| EPS Diluted Before Non-Recurring Items | -11.29 | -13.10 | -10.10 | -10.40 | -9.50 |
| EBITDA(a) | $-94,349 | $-116,953 | $-71,328 | $-51,288 | $-41,089 |